CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Consolidated net income	$ 500,486	$ 498,390	$ 399,876
Adjustments to reconcile consolidated net income to net cash provided by operations:
Depreciation and amortization	155,754	156,048	131,141
Amortization of stock-based compensation	47,274	41,930	36,923
Equity in earnings of affiliated companies	(7,037)	(7,318)	(7,429)
Deferred income taxes	5,833	(25,744)	273
Restructuring, integration, and other charges	51,305	29,324	65,601
Trade name impairment charge	0	78,000	0
Gain on sale of investment	(2,008)	(18,269)	0
Excess tax benefits from stock-based compensation arrangements	(5,911)	(7,129)	(7,172)
Other	10,894	2,686	3,534
Change in assets and liabilities, net of effects of acquired businesses:
Accounts receivable	(68,990)	(521,613)	(572,886)
Inventories	(42,790)	(210,789)	(21,277)
Accounts payable	33,398	628,697	446,814
Accrued expenses	4,834	12,396	(123,969)
Other assets and liabilities	(27,963)	16,692	99,262
Net cash provided by operating activities	655,079	673,301	450,691
Cash flows from investing activities:
Cash consideration paid for acquired businesses	(514,731)	(162,881)	(367,940)
Acquisition of property, plant, and equipment	(154,800)	(122,505)	(116,162)
Proceeds from sale of facilities	3,496	0	0
Proceeds from sale of investment	2,008	40,542	0
Purchase of cost method investments	0	0	(3,000)
Net cash used for investing activities	(664,027)	(244,844)	(487,102)
Cash flows from financing activities:
Change in short-term and other borrowings	(46,645)	(12,541)	(31,340)
Proceeds from (repayment of) long-term bank borrowings, net	(128,000)	(145,000)	71,400
Net proceeds from note offering	688,162	0	591,156
Redemption of notes	(254,313)	0	(338,184)
Proceeds from exercise of stock options	14,900	21,788	36,014
Excess tax benefits from stock-based compensation arrangements	5,911	7,129	7,172
Repurchases of common stock	(356,434)	(304,763)	(362,793)
Other	(7,768)	(1,499)	0
Net cash used for financing activities	(84,187)	(434,886)	(26,575)
Effect of exchange rate changes on cash	(34,130)	16,182	43,904
Net increase (decrease) in cash and cash equivalents	(127,265)	9,753	(19,082)
Cash and cash equivalents at beginning of year	400,355	390,602	409,684
Cash and cash equivalents at end of year	$ 273,090	$ 400,355	$ 390,602

This item represents the net total realized and unrealized gain (loss) included in earnings for the period, net of tax, as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholder's equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized, net of tax, during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments.

No definition available.